telmisartan has been researched along with Cancer of Lung in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 7 (77.78) | 24.3611 |
2020's | 2 (22.22) | 2.80 |
Authors | Studies |
---|---|
Arthur, P; Gebeyehu, A; Kalvala, AK; Mondal, A; Nottingham, E; Patel, N; Rishi, AK; Singh, M; Surapaneni, SK | 1 |
Banerjee, J; Bharadwaj, S; Foran, E; Green, R; Howell, M; Katiri, S; Khalil, R; Mohapatra, S; Mohapatra, SS; Nair, R; Singh, M; Yan, J | 1 |
Arthur, P; Bagde, A; Gebeyehu, A; Kutlehria, S; Mondal, A; Nottingham, E; Patel, N; Singh, M; Surapaneni, SK | 1 |
Lee, JH; Moon, JH; Nazim, UM; Park, SY; Rasheduzzaman, M | 1 |
Doddapaneni, R; Godugu, C; Jackson, T; Marepally, S; Patel, AR; Singh, M | 1 |
Chen, L; Li, J; Liu, B; Yang, Y; Yu, P; Zhu, J | 1 |
Behl, G; Boakye, CH; Chowdhury, N; Doddapaneni, R; Patel, K; Singh, M | 1 |
Azoulay, L; Bartels, DB; Dell'Aniello, S; Suissa, S; Tascilar, K | 1 |
Debanne, SM; Fang, JC; Rowland, DY; Simon, DI; Sipahi, I | 1 |
1 review(s) available for telmisartan and Cancer of Lung
Article | Year |
---|---|
Angiotensin-receptor blockade and risk of cancer: meta-analysis of randomised controlled trials.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Benzoates; Breast Neoplasms; Drug Therapy, Combination; Female; Humans; Lung Neoplasms; Male; Neoplasms; Prostatic Neoplasms; Randomized Controlled Trials as Topic; Risk; Telmisartan | 2010 |
8 other study(ies) available for telmisartan and Cancer of Lung
Article | Year |
---|---|
Telmisartan Facilitates the Anticancer Effects of CARP-1 Functional Mimetic and Sorafenib in Rociletinib Resistant Non-small Cell Lung Cancer.
Topics: Acrylamides; Animals; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Cell Survival; Down-Regulation; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Lung Neoplasms; Mice; Mice, Nude; Pyrimidines; Sorafenib; Spheroids, Cellular; Spiro Compounds; Telmisartan; Thiadiazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2021 |
Actinomycin D and Telmisartan Combination Targets Lung Cancer Stem Cells Through the Wnt/Beta Catenin Pathway.
Topics: Animals; Apoptosis; beta Catenin; Cell Line, Tumor; Cell Proliferation; Dactinomycin; Humans; Lung Neoplasms; Mice; Mice, Inbred C57BL; Mice, Inbred NOD; Neoplasm Recurrence, Local; Neoplastic Stem Cells; Signal Transduction; Telmisartan; Wnt Signaling Pathway | 2019 |
Targeting lung cancer stem cells using combination of Tel and Docetaxel liposomes in 3D cultures and tumor xenografts.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cell Culture Techniques; Cell Line, Tumor; Docetaxel; Drug Delivery Systems; Female; Humans; Liposomes; Lung Neoplasms; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplastic Stem Cells; Telmisartan; Xenograft Model Antitumor Assays | 2020 |
Telmisartan generates ROS-dependent upregulation of death receptor 5 to sensitize TRAIL in lung cancer via inhibition of autophagy flux.
Topics: A549 Cells; AMP-Activated Protein Kinases; Apoptosis; Autophagy; Humans; Lung Neoplasms; Molecular Targeted Therapy; Phosphorylation; Reactive Oxygen Species; Receptors, TNF-Related Apoptosis-Inducing Ligand; Telmisartan; TNF-Related Apoptosis-Inducing Ligand; Up-Regulation | 2018 |
Inhalation delivery of Telmisartan enhances intratumoral distribution of nanoparticles in lung cancer models.
Topics: Administration, Inhalation; Animals; Antineoplastic Agents; Benzimidazoles; Benzoates; Cell Line, Tumor; Collagen; Female; Humans; Losartan; Lung; Lung Neoplasms; Mice; Nanoparticles; Telmisartan | 2013 |
Telmisartan exerts anti-tumor effects by activating peroxisome proliferator-activated receptor-γ in human lung adenocarcinoma A549 cells.
Topics: Adenocarcinoma; Adenocarcinoma of Lung; Antineoplastic Agents; Benzimidazoles; Benzoates; Cell Line, Tumor; Cell Survival; DNA-Binding Proteins; Dose-Response Relationship, Drug; Humans; Intercellular Adhesion Molecule-1; Lung Neoplasms; Matrix Metalloproteinase 9; PPAR gamma; RNA, Messenger; Telmisartan | 2014 |
Tumor stromal disrupting agent enhances the anticancer efficacy of docetaxel loaded PEGylated liposomes in lung cancer.
Topics: A549 Cells; Animals; Antineoplastic Agents; Benzimidazoles; Benzoates; Coumarins; Docetaxel; Female; Heterografts; Humans; Liposomes; Lung Neoplasms; Mice; Mice, Nude; Particle Size; Polyethylene Glycols; Rats; Rats, Sprague-Dawley; Surface Properties; Taxoids; Telmisartan; Thiazoles; Tumor Burden | 2016 |
The Use of Telmisartan and the Incidence of Cancer.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Benzimidazoles; Benzoates; Breast Neoplasms; Colorectal Neoplasms; Databases, Factual; Humans; Incidence; Lung Neoplasms; Male; Middle Aged; Proportional Hazards Models; Prostatic Neoplasms; Risk Assessment; Risk Factors; Telmisartan; Time Factors; United Kingdom | 2016 |